期刊文献+

78例三阴性乳腺癌的临床分析

暂未订购
导出
摘要 目的探讨三阴性乳腺癌的临床特征及预后情况。方法收集2000年3月至2007年8月间,本院收治的78例三阴性乳腺癌患者,回顾性分析其临床病理资料及预后相关因素。结果 78例TNBC患者的中位年龄为51岁(32~73岁),发病年龄≤35岁者9例(11.5%);绝经前患者47例(60.3%);有乳腺癌家族史(≥1个Ⅰ级亲属患乳腺癌)6例(7.7%),淋巴结阳性患者49例(62.8%),肿瘤最大径≥5cm者12例(15.4%),浸润性导管癌66例(85%);病理分级Ⅰ级12例(15.4%),Ⅱ级48例(61.5%),Ⅲ级18例(23.15%);病理分期Ⅰ期11例(14.1%),Ⅱ期40例(51.3%),Ⅲ期22例(28.2%),Ⅳ期5例(6.4%)。术后3年内复发转移者37例(78.7%),3年总生存率69.4%,3年无疾病进展生存率为48.6%。结论三阴性乳腺癌具有确诊时原发肿瘤较大、病理分期较晚、病理分级较高、淋巴结转移数目较多、术后早期复发转移率较高等特征,淋巴结转移数目是三阴性乳腺癌预后的独立指标。
作者 任伟丽
出处 《浙江创伤外科》 2012年第3期341-343,共3页 Zhejiang Journal of Traumatic Surgery
  • 相关文献

参考文献11

  • 1……’陈灿明,沈镇宙,邵志敏.乳腺癌病理学进展[M].上海:科学技术文献出版社,2004,56-78.
  • 2Nielsen To, Hsu FD, Jensen K, et al. Im- munohistochemical and clinical character- ization of the basal-like subtype of inva- sive breast carcinoma[J]. Clin Cancer Res, 2004, 10: 5367-5374.
  • 3Bauer K R.Brown M, Cress R D, et al. De- scriptive analysis of estrogen receptor(ER) -negative,progesterone receptor(PR) nega- tive,and HER-2-negative invasive breast cancer, the socalled triple-negative pheno- type: a population-based study From the Califormia cancer Registry [J]. Cancer, 2007, 109:1721-1728.
  • 4蔡铭泉,陈强,施纯枚.受体三阴性乳腺癌的研究进展[J].临床肿瘤学杂志,2009,14(3):283-287. 被引量:17
  • 5Rakha E A, EI Sayed M E, Green A R. Prognostic markers intriple -negative breast cancer[J]. Cancer, 2007. 109: 25.
  • 6Nielsen T O, Hsu F D, Jensen K, et al. Immunohistochemical and clinical charac- terizaton of the basal-like subtype of in- vasive breast carcinoma [J]. Clin Cancer Res, 2004, 10: 5367-5374.
  • 7Banerjee S, Reis Filho J S, Ashley S, et al. Basl-like breast carcinomas: clinical outcome and response to chemotherapy[J]. J Chn Pathol, 2006, 59: 729-735.
  • 8Dent R, Trudeau M, Pritchard K I, et al. Triple-negative Breast cancer: clinical features and patterns of recurrence[J]. Clin Cancer Res, 2007, 13: 4429-4434.
  • 9赵晶,付丽.乳腺癌的分子分型[J].中华乳腺病杂志(电子版),2009,3(2):35-40. 被引量:34
  • 10王姝姝,范林军.三阴性乳腺癌患者远处复发转移的位置及临床结果:高发的脑转移率[J].中华乳腺病杂志(电子版),2009,3(1):60-62. 被引量:6

二级参考文献85

  • 1Perou CM, Sorlie T, Eisen MB, et al. Molecular portraits of human breast tumours[ J]. Nature ,2000,406 : 747 - 752.
  • 2Nielsen TO, Hsu FD, Jensen K, et al. Immunohistochenical and clinical characterization of the basal-like subtype of invasive breast carcinoma [ J ]. Clin Cancer Res, 2004,10 ( 16 ) :5367 - 5374.
  • 3Bertucci F. How basal are triple-negative breast cancers? [ J]. Int J Cancer,2008,123 ( 1 ) : 936 - 240.
  • 4Sasa M, Bando Y,Takahashi M, et al. Screening for basal marker expression is necessary for decision of therapeutic strategy tbr triple-negative breast cancer [ J ]. J Surg Oncol, 2008,97 ( 1 ) : 30-34.
  • 5Cleator S, Heller W, Coombes RC. Triple-negative breast cancer: therapeutic options [ J ]. Lancet Oncol,2007,8 : 235 - 244.
  • 6Foulkes WD, Stefansson IM, Chappuis PO, et al. Germline BRCAI mutations and a basal epithelial phenotype in breast cancer[J]. J Natl Cancer Inst,2003,95 : 1482 - 1485.
  • 7Korsehing E, Packeisen J, Agelopoulos K,et al. Cytogenetic alterations and cytokeratin expression patterns in breast cancer: integrating a new model of breast differentiation into cytogenelic pathways of breast carcinogenesis[ J ]. Lab Invest,2002,82 : 1525 - 1533.
  • 8Foulkes WD, Brunet JS, Stefansson IM,et al. The prognostic implication of the basal-like (cyclin E^high/p27^low/p53^+/ glomeruloid-microvascular-proliferation^+ ) phenotype of BRCA1-related breast cancer[ J]. Cancer Res,2004, 64 : 830 - 835.
  • 9Bergamaschi A, Kim YH,Wang P,et al. Distinct patterns of DNA copy number alteration are associated with different clinieopathological features and gene-expression subtypes of breast cancer [ J]. Genes Chromosomes Cancer, 2006,45 : 1033 - 1040.
  • 10Turner N, Tutt A, Ashworth A. Hallmarks of BRCkness' in sporadic caneers[J]. Nat Rev Cancer,2004-,4:814 -819.

共引文献60

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部